Exec Chat: J&J DePuy Synthes’ Sharrolyn Josse Outlines Strategy For VELYS Digital Surgery

In an interview with Medtech Insight, Sharrolyn Josse, worldwide president of VELYS Digital Surgery and Capital at Johnson & Johnson’s DePuy Synthes unit, outlines strategies that are driving the present and future VELYS robotic-assisted solution and its connected technologies.

Digital Future

This January, Johnson & Johnson (Pty) LtdDePuy Synthes announced it received US Food and Drug Administration 510(k) clearance for the VELYS Robotic-Assisted Solution designed for use with the Attune knee system. The solution simplifies surgeon’s workflow around total knee replacement and is part of the broader VELYS digital surgery platform of connected technologies, which can leverage data insights for patients, surgeons and health systems.

J&J obtained the VELYS technology by acquiring Orthotaxy SAS, a French developer of software-based surgical technologies, for an undisclosed...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Digital Technologies

More from Medtech Insight